{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:55:09Z","timestamp":1787064909549,"version":"build-2736575974"},"reference-count":127,"publisher":"Informa UK Limited","issue":"8","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Investigational Drugs"],"published-print":{"date-parts":[[2024,8,2]]},"DOI":"10.1080\/13543784.2024.2376566","type":"journal-article","created":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T06:24:14Z","timestamp":1719987854000},"page":"801-814","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":2,"title":["Monoclonal antibodies targeting interleukins for systemic lupus erythematosus: updates in early clinical drug development"],"prefix":"10.1080","volume":"33","author":[{"given":"Claudio","family":"Cruciani","sequence":"first","affiliation":[{"name":"Rheumatology Unit, Department of Medicine, University of Padua, Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariele","family":"Gatto","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Department of Clinical and Biological Sciences, University of Turin and Turin Mauriziano Hospital, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Iaccarino","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Department of Medicine, University of Padua, Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0548-4983","authenticated-orcid":false,"given":"Andrea","family":"Doria","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Department of Medicine, University of Padua, Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita","family":"Zen","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Department of Medicine, University of Padua, Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,7,9]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2024-225617"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1177\/0961203315627202"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2016-000157"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)05246-0"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-130-6-199903160-00004"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1912196"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.30613"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2023.105523"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/827254"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20246231"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri2572"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02285"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1610528"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.23678"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1402070"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1102321"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/89790"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61354-2"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2001180"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.41253"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2017.09.004"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-018-8675-2"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2021.102729"},{"issue":"4","key":"e_1_3_4_26_1","first-page":"449","article-title":"Efficacy and safety of off-label use of rituximab in refractory lupus: data from the Italian multicentre registry","volume":"33","author":"Iaccarino L","year":"2015","unstructured":"Iaccarino L, Bartoloni E, Carli L, et al. Efficacy and safety of off-label use of rituximab in refractory lupus: data from the Italian multicentre registry. Clin Exp Rheumatol [Internet]. 2015;33(4):449\u2013456. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26053285","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2016.18"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.38074"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.41466"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.7326\/M21-2078"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.23047"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.40360"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-205067"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1177\/0961203309102803"},{"key":"e_1_3_4_35_1","unstructured":"Di W Jing L Dong X et al. Telitacicept a human recombinant fusion protein targeting b lymphocyte stimulator (blys) and a proliferation-inducing ligand (April) in systemic lupus erythematosus (sle): results of a phase 3 study. ACR meeting abstracts [Internet]. Arthritis Rheumatol. [cited 2023 Oct 12]. Available from: https:\/\/acrabstracts.org\/abstract\/telitacicept-a-human-recombinant-fusion-protein-targeting-b-lymphocyte-stimulator-blys-and-a-proliferation-inducing-ligand-april-in-systemic-lupus-erythematosus-sle-results-of-a-phase-3-study\/"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2011.03.023"},{"key":"e_1_3_4_37_1","first-page":"906","article-title":"Development of an ICOSL and BAFF bispecific inhibitor AMG 570 for systemic lupus erythematosus treatment","volume":"37","author":"Zhang M","year":"2019","unstructured":"Zhang M, Lee F, Knize A, et al. Development of an ICOSL and BAFF bispecific inhibitor AMG 570 for systemic lupus erythematosus treatment. Clin Exp Rheumatol [Internet]. 2019;37:906\u2013914. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30789152","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2929"},{"key":"e_1_3_4_39_1","first-page":"575","article-title":"Emerging concepts of type I interferons in SLE pathogenesis and therapy","volume":"18","author":"Psarras A","year":"2022","unstructured":"Psarras A, Wittmann M, Vital EM. Emerging concepts of type I interferons in SLE pathogenesis and therapy. Nat Rev Rheumatol [Internet]. 2022;18:575\u2013590. Available from: https:\/\/www.nature.com\/articles\/s41584-022-00826-z","journal-title":"Nat Rev Rheumatol"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2010.64"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1191\/096120300674499064"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780250407"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gene.6364408"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1080\/08916930500285394"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/706825"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.23613"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.81"},{"key":"e_1_3_4_48_1","unstructured":"Remmers EF Plenge RM Lee AT et al. STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus from the national institute of arthritis and musculoskeletal and skin diseases Available from: www.nejm.org"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-015-0588-3"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M102502200"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(19)30076-1"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.34632"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-206090"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.144485"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.37824"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208562"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(20)30223-X"},{"key":"e_1_3_4_58_1","first-page":"5294","volume-title":"Proc Natl Acad Sci [Internet]","volume":"106","author":"Zagury D","year":"2009","unstructured":"Zagury D, Le Buanec H, Mathian A, et al. IFN\u03b1 kinoid vaccine-induced neutralizing antibodies prevent clinical manifestations in a lupus flare murine model. Proc Natl Acad Sci [Internet]; 2009;106:5294\u20135299. Available from: https:\/\/pnas.org\/doi\/full\/10.1073\/pnas.0900615106"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.141101"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.37785"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-216379"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2005.10.003"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI28508"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.1177\/1535370218824547"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217159"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-223296"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjab178"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.1177\/0961203312457718"},{"key":"e_1_3_4_69_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12865-015-0070-7"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2014.12.027"},{"key":"e_1_3_4_71_1","article-title":"The Th17\/IL-17 axis and kidney diseases, with focus on lupus nephritis","volume":"8","author":"Paquissi FC","year":"2021","unstructured":"Paquissi FC, Abensur H. The Th17\/IL-17 axis and kidney diseases, with focus on lupus nephritis. Front Med (Lausanne) [Internet]. 2021;8. Available from: https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.654912\/full","journal-title":"Front Med (Lausanne)"},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241914883"},{"key":"e_1_3_4_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32167-6"},{"key":"e_1_3_4_74_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-222858"},{"key":"e_1_3_4_75_1","doi-asserted-by":"publisher","DOI":"10.1177\/0961203318762598"},{"key":"e_1_3_4_76_1","unstructured":"Costa R Antunes P Salvador P et al. Secukinumab on refractory lupus nephritis. Cureus. Available from: https:\/\/www.cureus.com\/articles\/63741-secukinumab-on-refractory-lupus-nephritis"},{"key":"e_1_3_4_77_1","doi-asserted-by":"publisher","DOI":"10.1191\/0961203304lu1023oa"},{"key":"e_1_3_4_78_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.iy.08.040190.001345"},{"key":"e_1_3_4_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2020.115327"},{"key":"e_1_3_4_80_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1613849"},{"key":"e_1_3_4_81_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.22033"},{"key":"e_1_3_4_82_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2303452"},{"key":"e_1_3_4_83_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-007-9104-0"},{"key":"e_1_3_4_84_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.1998.00612.x"},{"issue":"5","key":"e_1_3_4_85_1","first-page":"927","article-title":"Interleukin-6 exacerbates glomerulonephritis in (NZB x NZW)F1 mice","volume":"144","author":"Ryffel B","year":"1994","unstructured":"Ryffel B, Car BD, Gunn H, et al. Interleukin-6 exacerbates glomerulonephritis in (NZB x NZW)F1 mice. Am J Pathol [Internet]. 1994;144(5):927\u2013937. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8178944","journal-title":"Am J Pathol"},{"key":"e_1_3_4_86_1","doi-asserted-by":"publisher","DOI":"10.1177\/03000605221088558"},{"key":"e_1_3_4_87_1","doi-asserted-by":"publisher","DOI":"10.3109\/14397595.2014.990409"},{"key":"e_1_3_4_88_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.27221"},{"key":"e_1_3_4_89_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-201310"},{"key":"e_1_3_4_90_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24065994"},{"key":"e_1_3_4_91_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-019-0244-y"},{"key":"e_1_3_4_92_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1201216"},{"key":"e_1_3_4_93_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.21062"},{"key":"e_1_3_4_94_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0060001"},{"key":"e_1_3_4_95_1","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200425830"},{"key":"e_1_3_4_96_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1001983"},{"key":"e_1_3_4_97_1","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/4832543"},{"key":"e_1_3_4_98_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2008.191"},{"key":"e_1_3_4_99_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri3804"},{"key":"e_1_3_4_100_1","first-page":"1450.2","volume-title":"Pharmacokinetics and pharmacodynamics of pf-06835375 in patients with seropositive systemic lupus erythematosus or rheumatoid arthritis. Scientific abstracts [internet]","author":"Cohen S","year":"2023","unstructured":"Cohen S, Beebe J, Chindalore V, et al. AB0511\u2005AB0511\u2005A phase 1, randomised, double-blind, placebo-controlled, single- and multiple-dose escalation study to evaluate the safety. In: Pharmacokinetics and pharmacodynamics of pf-06835375 in patients with seropositive systemic lupus erythematosus or rheumatoid arthritis. Scientific abstracts [internet]. BMJ Publishing Group Ltd and European League Against Rheumatism; 2023. p. 1450.2\u20131450. Available from: https:\/\/ard.bmj.com\/lookup\/doi\/10.1136\/annrheumdis-2023-eular.95"},{"key":"e_1_3_4_101_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri2916"},{"key":"e_1_3_4_102_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-021-00707-x"},{"key":"e_1_3_4_103_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-214229"},{"key":"e_1_3_4_104_1","first-page":"204","volume-title":"Proc Nat Acad Sci [Internet]","volume":"107","author":"Humrich JY","year":"2010","unstructured":"Humrich JY, Morbach H, Undeutsch R, et al. Homeostatic imbalance of regulatory and effector T cells due to IL-2 deprivation amplifies murine lupus. Proc Nat Acad Sci [Internet]; 2010;107:204\u2013209. Available from: https:\/\/pnas.org\/doi\/full\/10.1073\/pnas.0903158107"},{"key":"e_1_3_4_105_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-207776"},{"key":"e_1_3_4_106_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-222501"},{"key":"e_1_3_4_107_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-eular.2097"},{"key":"e_1_3_4_108_1","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/294582"},{"key":"e_1_3_4_109_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.120468"},{"issue":"2","key":"e_1_3_4_110_1","first-page":"172","article-title":"Interleukin-21 is increased in active systemic lupus erythematosus patients and contributes to the generation of plasma B cells","volume":"31","author":"Nakou M","year":"2013","unstructured":"Nakou M, Papadimitraki ED, Fanouriakis A, et al. Interleukin-21 is increased in active systemic lupus erythematosus patients and contributes to the generation of plasma B cells. Clin Exp Rheumatol [Internet]. 2013;31(2):172\u2013179. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23137515","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_4_111_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.075424"},{"key":"e_1_3_4_112_1","doi-asserted-by":"publisher","DOI":"10.1111\/cts.12715"},{"key":"e_1_3_4_113_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.970906"},{"key":"e_1_3_4_114_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep34604"},{"key":"e_1_3_4_115_1","doi-asserted-by":"publisher","DOI":"10.1177\/0961203312462267"},{"key":"e_1_3_4_116_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2003.12.005"},{"key":"e_1_3_4_117_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2016.06.014"},{"key":"e_1_3_4_118_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kex444"},{"key":"e_1_3_4_119_1","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2014-000066"},{"key":"e_1_3_4_120_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-220920"},{"key":"e_1_3_4_121_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2023325"},{"key":"e_1_3_4_122_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2118025"},{"key":"e_1_3_4_123_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-02017-5"},{"key":"e_1_3_4_124_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.42391"},{"key":"e_1_3_4_125_1","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2018-000280"},{"key":"e_1_3_4_126_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-023-00925-5"},{"key":"e_1_3_4_127_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.39809"},{"key":"e_1_3_4_128_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23361-z"},{"key":"e_1_3_4_129_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-018-0133-2"}],"container-title":["Expert Opinion on Investigational Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13543784.2024.2376566","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T11:48:59Z","timestamp":1727264939000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13543784.2024.2376566"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,9]]},"references-count":127,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8,2]]}},"alternative-id":["10.1080\/13543784.2024.2376566"],"URL":"https:\/\/doi.org\/10.1080\/13543784.2024.2376566","relation":{},"ISSN":["1354-3784","1744-7658"],"issn-type":[{"value":"1354-3784","type":"print"},{"value":"1744-7658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,9]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-01-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}